| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S11095-005-9571-Z |
| P698 | PubMed publication ID | 16525862 |
| P2093 | author name string | Mats O Karlsson | |
| Rikard Sandström | |||
| Mats O Magnusson | |||
| P2860 | cites work | Xpose--an S-PLUS based population pharmacokinetic/pharmacodynamic model building aid for NONMEM | Q77296898 |
| Dose-dependence and repeated-dose studies for receptor/gene-mediated pharmacodynamics of methylprednisolone on glucocorticoid receptor down-regulation and tyrosine aminotransferase induction in rat liver | Q78255498 | ||
| Protein measurement with the Folin phenol reagent | Q20900776 | ||
| A mechanistic approach to antiepileptic drug interactions | Q34469990 | ||
| A semiphysiological pharmacokinetic model for artemisinin in healthy subjects incorporating autoinduction of metabolism and saturable first-pass hepatic extraction | Q35826682 | ||
| A mechanism-based pharmacokinetic-enzyme model for cyclophosphamide autoinduction in breast cancer patients | Q36053763 | ||
| Evaluation of the autoinduction of ifosfamide metabolism by a population pharmacokinetic approach using NONMEM. | Q36055447 | ||
| Preparation and characterization of subcellular fractions from the liver of C57B1/6 mice, with special emphasis on their suitability for use in studies of epoxide hydrolase activities | Q36465235 | ||
| Interpulse interval in circulating growth hormone patterns regulates sexually dimorphic expression of hepatic cytochrome P450. | Q37568745 | ||
| Purification and characterization of hepatic microsomal cytochrome P-450. | Q38140214 | ||
| Enzyme induction in the cytochrome P-450 system | Q38140216 | ||
| Genetic regulation of UDP-glucuronosyltransferase induction by polycyclic aromatic compounds in mice. Co-segregation with aryl hydrocarbon (benzo(alpha)pyrene) hydroxylase induction | Q39432183 | ||
| Interactions of hepatic cytochromes P-450 with steroid hormones. Regioselectivity and stereospecificity of steroid metabolism and hormonal regulation of rat P-450 enzyme expression | Q39626603 | ||
| Time-Dependent Kinetics IV: Pharmacokinetic Theory of Enzyme Induction | Q39650277 | ||
| Foreign compound metabolism in the liver. | Q40337381 | ||
| Pharmacokinetic interactions between antiepileptic drugs. Clinical considerations | Q41271354 | ||
| Substrate specificity for rat cytochrome P450 (CYP) isoforms: screening with cDNA-expressed systems of the rat. | Q43930653 | ||
| Quantitative analysis of eight testosterone metabolites using column switching and liquid chromatography/tandem mass spectrometry | Q44901614 | ||
| Phenobarbital N-glucosylation by human liver microsomes | Q44901727 | ||
| Time course of enzyme induction in humans: effect of pentobarbital on nortriptyline metabolism | Q47722116 | ||
| Non-steady state population kinetics of intravenous phenytoin. | Q52237495 | ||
| Regulation of testosterone hydroxylation by rat liver microsomal cytochrome P-450. | Q52256485 | ||
| Time course of enzyme induction in liver and kidneys and absorption, distribution and elimination of 1,4-dichlorobenzene in rats. | Q52568113 | ||
| Regioselectivity and stereoselectivity of androgen hydroxylations catalyzed by cytochrome P-450 isozymes purified from phenobarbital-induced rat liver | Q58483896 | ||
| The in vivo turnover of rat liver microsomal epoxide hydrolase and both the apoprotein and heme moieties of specific cytochrome P-450 isozymes | Q64764696 | ||
| 40 Induction of cytochromes P450IA1 and P450IA2 and measurement of catalytic activities | Q67842846 | ||
| Isozyme specificity of testosterone 7 alpha-hydroxylation in rat hepatic microsomes: is cytochrome P-450a the sole catalyst? | Q69438795 | ||
| Mechanism of androstenedione formation from testosterone and epitestosterone catalyzed by purified cytochrome P-450b | Q70221677 | ||
| Fast determination of low-level cytochrome P-450 1A1 activity by high-performance liquid chromatography with fluorescence or visible absorbance detection | Q71542352 | ||
| Multiple forms of human P450 expressed in Saccharomyces cerevisiae. Systematic characterization and comparison with those of the rat | Q71675102 | ||
| Simultaneous liquid chromatographic determination of chloramphenicol and antiepileptic drugs (phenobarbital, phenytoin, carbamazepine, and primidone) in plasma | Q71719831 | ||
| Effects of felbamate on the pharmacokinetics of phenobarbital | Q71731576 | ||
| The kinetics of the auto-induction of ifosfamide metabolism during continuous infusion | Q72163464 | ||
| Pharmacokinetic consequences of induction of CYP2E1 by ligand stabilization | Q73756800 | ||
| P433 | issue | 3 | |
| P304 | page(s) | 521-532 | |
| P577 | publication date | 2006-03-15 | |
| P1433 | published in | Pharmaceutical Research | Q7180737 |
| P1476 | title | A mechanism-based integrated pharmacokinetic enzyme model describing the time course and magnitude of phenobarbital-mediated enzyme induction in the rat. | |
| P478 | volume | 23 |
| Q46842745 | Absolute quantification and modulation of cytochrome P450 3A isoforms in cattle liver |
| Q34571036 | Improved prediction of tacrolimus concentrations early after kidney transplantation using theory-based pharmacokinetic modelling |
| Q42703910 | Liver tumor formation in female rat induced by fluopyram is mediated by CAR/PXR nuclear receptor activation |
| Q38207924 | Treatment optimization in patients co-infected with HIV and Mycobacterium tuberculosis infections: focus on drug-drug interactions with rifamycins |
Search more.